Addiction Prevention

JanOne, treating the opioid industry and bringing to market drugs with non-addictive pain-relieving properties

 
 
Tony Giordano, PhD and Chief Scientific Officer of JanOne (NASDAQ: JAN), which is focused on developing treatments for diseases that cause severe pain joins eHealth Radio and and the Health News and Pain Management Channels.
Listen to interview with host Eric Michaels and guest Tony Giordano, PhD discuss the following:
Can you tell me a bit about yourself and how you got interested in reducing the need for opioid prescriptions that led to your involvement with JanOne?
Please give us an overview of JAN101 and its recent developments.
It is estimated that 40% of opioid overdose deaths involve prescription opioids, how is JanOne tackling the issue?
What is Jan’s main focus when treating diseases that cause pain to millions around the world?
Could you please give us some insight on Jan’s treatment for PAD and how PAD can affect patients?
JanOne (NASDAQ: JAN) is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid prescriptions to treat disease-associated pain that can lead to opioid abuse. The company is also exploring solutions for non-addictive pain medications. Its lead candidate JAN101 is for treating peripheral artery disease (PAD), a condition that affects over 8.5 million Americans. JAN101 demonstrated positive results in a Phase 2a clinical trial, and Phase 2b trials are expected to begin in early 2021. JanOne is dedicated to funding resources toward innovation, technology, and education for PAD, associated vascular conditions and neuropathic pain. JanOne continues to operate its legacy businesses under their current brand names, which are undergoing review to determine appropriate strategic alternatives
 
 
Website: https://janone.com
Social Media Links: Facebook: facebook.com/JanOneOfficial  Linkedin: linkedin.com/company/janone  Twitter: twitter.com/JanOne

How the COVID-19 Pandemic is Worsening the Opioid Crisis

 
 
Dr. Joseph DeSanto, an Addiction Specialist with BioCorRx Inc., an addiction treatment solutions company targeting substance use and other related disorders joins eHealth Radio and the Addiction Prevention and Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Joseph DeSanto discuss the following:
How has COVID-19 exasperated the US opioid crisis?
What added factors may cause addicts to relapse during the pandemic?
How has telehealth helped serve the addiction recovery community? Can you tell me how BioCorRx uses telehealth?
What makes the Beat Addiction Recovery Program unique?
With the winter holidays approaching, why are addicts more likely to relapse?
How can family members help loved ones get help and navigate their addiction during these unprecedented times?
Dr. Joseph DeSanto is a Board Certified Addictionologist for DeSanto Clinics and addiction specialist with addiction treatment solutions company, BioCorRx. He has more than 12 years of experience practicing medicine, is a graduate of Lafayette College and attended the State University of New York at Downstate in Brooklyn for his medical school training. He completed his internship and residency training at Cedars Sinai Medical Center in Los Angeles and is Board Certified by the American Board of Internal Medicine. In addition to his role with BioCorRx, he serves as a medical consultant for a number of treatment centers in Orange County, CA.
 
Website: BeatAddiction.com
Social Media Links: Twitter: twitter.com/biocorrxinc  Facebook: facebook.com/BioCorRx

Staying Sober in Quarantine: How to Help Those Struggling with Addiction in Trying Times

 
 
Erin Khar, an author from New York City whose debut memoir, Strung Out: One Last Hit and Other Lies that Nearly Killed Me, tackles the issues that many people face as they travel the road of addiction recovery joins eHealth Radio and the Addiction Prevention and Health News Channels. She has dedicated her life to shining light on these issues and helping others find their way to sobriety, especially in the face of adversity.
Listen to interview with host Eric Michaels and guest Erin Khar discuss the following:
What challenges are people who have addiction issues encountering during the pandemic?
Where and how can they find help at this time when people are unable to gather for meetings or counseling?
How can loved ones help from a distance?
What's your personal advice for people facing addiction issues? What's helped you personally to remain clean?
There's a movement now called Dry July. How can people manage to carry sobriety beyond this one month?
 
 
Erin Khar recently released her debut memoir, Strung Out: One Last Hit and Other Lies that Nearly Killed Me (Park Row Books, 2/25/20), has appeared on most anticipated lists from The Rumpus, SELF, Apple Books, Goodreads, Bitch Media, Alma, and others. Of the book, The New York Times writes, Khar’s buoyant writing doesn’t get mired in her dark subject matter. There is an honesty here that can only come from, to put it in the language of 12-step programs, a “searching and fearless moral inventory.” This is a story she needed to tell; and the rest of the country needs to listen.
 
 
Website: www.erinkhar.com
Social Media Links: Facebook: facebook.com/ErinKharAuthor  Instagram: instagram.com/erinkhar  Twitter: twitter.com/ErinKhar

Cutting Back on Alcohol with a Science-based Program

 
 
Katie Lain, the Director of Community Engagement at Ria Health that provides at-home, evidence-based alcohol treatment through telemedicine joins eHealth Radio and the Addiction Prevention and Telemedicine Channels.
Listen to interview with host Eric Michaels and guest Katie Lain discuss the following:
Can you tell us more about Ria Health and how it helps people who want to drink less alcohol, or even stop for good?
So if a person is finding it hard to control how much they drink, but they also don’t want to go 100% abstinent, what other options do they have?
But if someone does want to go abstinent, these methods can help as well?
How did you get involved with Ria?
In your experience, how would someone know if they are drinking too much and need to seek support to cut back or stop?
TIP: If you’re someone who is experiencing regular hangovers, or find you NEED alcohol to unwind every night or weekend, consider looking into evidence-based treatments and medication therapy. Abstinence is not required, it can be done discreetly and evidence shows that it is effective for many people – resulting in more control over their alcohol consumption, or giving it up more easily without battling alcohol cravings.
 
 
Katie Lain is the Director of Community Engagement with Ria Health. Ria’s science-backed platform is for anybody who wants to drink less alcohol and live a better life. Their evidence-based program is delivered through telehealth which means it’s accessible from anywhere using a HIPAA-compliant app.
 
Ria’s program provides both harm-reduction and abstinence based methods that include physician guided care plans, one-on-one coaching, medication therapy, peer group support and digital tools to track progress. Since Ria began in 2016, they have served over 1500 people and counting who want to improve their relationship with alcohol.
 
Ria Health is also covered by many major health insurers across the US, and on average, Ria Members see a 75% reduction in their Blood Alcohol Concentration (BAC) levels after 12 months in the program.
 
Katie Lain joined Ria Health after she overcame alcohol addiction through this evidence-based treatment method. She now works both professionally and personally to raise awareness about these options for treating alcohol dependence.
 
 
Website: https://riahealth.com
 
Social Media Links: Facebook: facebook.com/RiaHealth  Instagram: instagram.com/riahealth  Twitter: twitter.com/RiaHealthSF  LinkedIn: linkedin.com/company/riahealth  YouTube: youtube.com/c/riahealth

Overcoming addictive eating by changing your relationship with yourself and food

 
 
Sandra Elia a Certified Food Addiction Counselor and a pioneer in the field of overcoming addictive eating joins eHealth Radio and the Addictive Prevention & Health News Channels.
 
Listen to interview with host Eric Michaels & guest Sandra Elia discuss the following:
Tell us about your own journey recovering from food addiction.
What is food addiction?
How have you influenced the medical community in the treatment of obesity management?
What is appetite correction?
How can we manage food cravings?
Tell us about your Food Addiction Recovery Program?
How are you able to achieve lifelong results through Food Addiction recovery treatment?

Sandra Elia is a Certified Food Addiction Counselor. She runs Ontario's outpatient Food Addiction Recovery Program and co-created Canada's first residential treatment program.
Sandra is a Coaches Training Institute (CTI) Certified Professional Coach and the Vice-Chair for Obesity Canada (Toronto Chapter).
Sandra is dedicated to changing the conversation for obesity so that anyone living with obesity has access to treatment that is steeped with dignity, respect, and understanding. Sandra knows firsthand the challenges associated with living with obesity. She has lived two lives: one as a morbidly obese woman for 15 years. She experienced a world that was not made for her size, seeking assistance from biased healthcare providers, and dealing with fat-shaming. Since those difficult days, Sandra has transformed her life, losing over 100 pounds and keeping the weight off for 14 years. Obesity is not simply about body weight or body image. It's about human vulnerability. Behind every obesity statistic, is a real person living with physical, mental, and emotional challenges.
 
 
 
Website: sandraelia.com
Social Media Links: Facebook: facebook.com/foodaddictionprogram  Twitter: @sandraelia_ca Instagram: sandraelia.ca

Food addiction: A Bite Size Explanation

 
 
Dr. Vera Tarman, addictions specialist and Medical Director of Renascent, an inpatient drug and alcohol treatment centre in Canada, as well as the author of Food Junkies: the Truth about Food Addiction joins eHealth Radio and the Addiction Prevention and Health News Channels joins eHealth Radio.
 
Listen to interview with host Eric Michaels and guest Dr. Vera Tarman discuss the following:
Is food really addictive?
What foods are addictive?
Why do we care? Why is it so Important to acknowledge Food Addiction?
What does food recovery (from the obsession to eat) mean?
Do you have to stop eating sugar. Forever?
Why do diets not work? Why can you lose weight only to gain back only more? How does this relate to the growing obesity crisis?

Dr. Vera Tarman is the Medical Director of Renascent, Canada’s largest drug and alcohol residential treatment centre. Dr Tarman is currently overseeing Renascent’s unique 28 day live-in treatment program for women with food addiction. She has treated over 100 food addicts, and can attest that food addiction is as serious as all other addictions. She is the author of Food Junkies: The Truth about Food Addiction, and has spoken internationally on the subject of sugar / carb addiction.
Dr. Tarman is herself in recovery from food addiction and has sustained a weight loss of 100 pounds for over 10 years, mainly by following a healthy and delicious food abstinent plan. She is passionate about her subject, which she sees is personal. She maintains a website: AddictionsUnplugged.com and encourages you to join her Facebook page: “I’m Sweet Enough: Sugar Free for life Support Group Page”.
 
 
Media links: Speaker One link: Dr_Vera_Tarman_One_Sheet_Print Website: veratarmanMD.com | addictionsunplugged.com Email: veratarmanmd@gmail.com Youtube: https://www.youtube.com/c/VeraTarmanMD Linkedin: https://www.linkedin.com/in/drveratarman Amazon: amazon.com/author/food-junkies Amazon CA: http://bit.ly/FoodJunkiesRecoveryFromFoodAddiction Amazon: http://bit.ly/FoodJunkiesRecoveryfromFA Twitter: @addunplug

RDx BioScience Fights Opioid Crisis

 
 
Dr. Scott Howell, D.O., MPH & TM, CPE, Chief Medical Officer of RDx BioScience, a single source for care quality, risk evaluation and opioid expertise powered by a fast, full-service laboratory joins eHealth Radio and the Health News and Pharmaceutical Channels.
 
Listen to interview with host Eric Michaels & guest Dr. Scott Howell discuss the following:
How are the new synthetic opioids, as we hear a lot about Fentanyl, different than an opiate like morphine?
Is Fentanyl responsible for overdose deaths?
What other risks are associated?
How does this impact employers?
What does RDx do to help tackle the addiction crisis?

Dr. Scott Howell is an acclaimed physician with over 25 years of clinical experience in medicine, public health and addiction. As the Chief Medical Officer for RDx BioScience, Scott leads our crusade to design and deliver meaningful value-based care. With expertise in the macro world of population health and day-to-day experience treating individual patients, he has deep insight into the capabilities of diagnostics in the diagnosis and treatment of chronic illness.

Scott brings extensive managed care experience with health plans, serving as National Senior Medical Director and Chief Medical Officer, Network and Population Health, Optum Insight, Regional Chief Medical Officer, Northeast Region of Americhoice, Inc., and National Medical Director of the Managed Care, AIDS Healthcare Foundation, with responsibility for international consulting in Russia, Ukraine, Guatemala, Honduras and Haiti. He most recently as Executive Medical Director at Heritage Provider Network.

He holds decades of hands-on practice experience, serving as Medical Director for the Broward Addiction and Recovery Center in Broward County, Florida, with oversight of a 40-bed detoxification center, 100-bed residential unit and over 5,000 outpatient visits per year in a public-funded setting. He continues to practice at Kaiser Permanente Los Angeles Medical Center’s Department of Addiction Medicine.

After serving in the U.S. military for 25 years, Dr. Howell is currently on military reserve assignment with the Office of Secretary of Defense at the Department of Defense Inspector General, concentrating on the Wounded Warrior Program, BioAssurity and Ebola Outbreak Assessment.

He earned a Master’s in Economics from the University of Miami, a Master’s in Public Health and Tropical Medicine from Tulane University, a Master’s in Business Administration (MBA) from California State University Fresno, and is certified by the American College of Physician Executives as a Certified Physician Executive (CPE).
 
 
Website: rdxbioscience.com
Social Media Links: Facebook: facebook.com/rdxbiosciences Twitter: @rdxbioscience

An idea that began in 2013 with the loss of a single life has helped save thousands of lives since

 
 
Dr. Caitlin Simpson, Director of Clinical Operations for Footprints to Recovery, a collection of drug and alcohol recovery treatment centers located across the United States joins eHealth Radio and the Addiction Prevention and the Health News Channels.
 
Listen to interview with host Eric Michaels & guest Dr. Caitlin Simpson discuss the following:
What is Footprints to Recovery? Where and when was it founded?
How many facilities operate under the Footprints to Recovery umbrella? Where are these facilities located?
What is Footprints to Recovery’s overarching mission? What are the current programs that Footprints to Recovery offers in support of this mission?
Can you give us a sense of the prevalence of drug and alcohol abuse in the United States?
If you could give one piece of advice for people seeking help for themselves or someone else, what would it be?
Conclusion: Footprints to Recovery is a collection of regional drug and alcohol treatment centers with headquarters in Chicago and facilities in Arizona, Illinois, Colorado, New Jersey and Pennsylvania. The company also operates a 24/7 call center to answer questions and support individuals in crisis.
Dr. Caitlin Simpson, LCSW, LCADC (MSW Fordham University and DSW Rutgers University) has twelve years of experience specializing in the field of addictions and co-occurring disorders, with a focus on the co-occurrence of trauma.
Dr. Simpson began her career in New Jersey at a private organization offering medicated assisted treatment, then advanced to the Superior Court of New Jersey, where she served as the Substance Abuse Evaluator for both the criminal division and drug court program. Through this position she became highly proficient in the areas of assessment and treatment recommendations in accordance with ASAM Criteria.
In 2010, following completion of graduate school, Dr. Simpson pursued a PhD in Social Work at Fordham University. After completing two years of doctoral research-based education, she transferred to Rutgers University to delve into the Doctorate in Social Work program, which offered a comprehensive advanced practice doctorate in clinical social work. Dr. Simpson then transitioned into various administrative roles as a clinical supervisor, program director and clinical director.
Currently, she serves as the Director of Clinical Operations with Footprints to Recovery. Dr. Simpson believes that through the mindful integration of traditional therapy, evidenced-based practice, and complementary holistic approaches, we can restore the well-being of the whole person: mind, body, brain, and spirit. She ensures special attention is paid to effectively and compassionately providing trauma-informed care and believes that the integration of mind, brain and body are essential in this realm.
 
 
Website: footprintstorecovery.com
Social Media Links: Facebook: facebook.com/FootprintsRehab  Twitter: @FootprintsRehab  Instagram: @footprintstorecovery

Alcoholism: Is there a medicinal solution on the horizon?

 
 
William Stilley the CEO of Adial Pharmaceuticals, a publicly traded company specializing in medicines that fight addiction joins eHealth Radio and the Addiction & Health News Channels.
The company’s first drug addresses those with a genetic predisposition to alcohol use disorder and is about to enter into a phase 3 clinical trial. It is estimated that alcohol is the leading cause of death globally among 15-49 year olds.
 
Listen to interview with host Eric Michaels & guest William Stilley discuss the following:
What is currently being done to fight and deal with alcohol addiction?
What is Adial Pharmaceutical’s solution to the alcohol addiction problem? Specifically how does your drug work?
How does someone get tested for a genetic predisposition? Can they get involved in your clinical trial?
Where can interested parties find out more and follow the advancement of your clinical trial?
Assuming you are successful in your trial, what’s next and when do you think this solution will be available?

William B. Stilley has served as the Chief Executive Officer since December 2010. Prior to joining Adial Pharmaceuticals, he was the Vice President, Business Development & Strategic Projects at Clinical Data, Inc. (NASDQ CLDA), where he worked on licensing and M&A transactions and was involved in management of Phase 3 clinical trials, production of Viibryd® for initial commercial launch of the product, and sourcing drug product and drug substance for the Phase 3 clinical trials of the Company’s vasodilator drug for myocardial stress imaging. Before entering the business community, Mr. Stilley served as Captain in the U.S. Marine Corps.
Mr. Stilley has an MBA with honors from the Darden School of Business and a B.S. in Commerce/Marketing from the McIntire School of Commerce at the University of Virginia. Until recently, he guest lectured at the Darden School of Business, two courses on the management of life science companies. He currently serves on the Board of Virginia BIO, the statewide biotechnology organization. He also holds a patent for Stedivaze®, which is currently in Phase 3 clinical development.
 
 
Website: www.adialpharma.com
Social Media Links: Facebook: https://www.facebook.com/adialpharma Twitter: https://twitter.com/AdialPharma Linkedin: https://www.linkedin.com/company/adial-pharmaceuticals

A Powerful Way to Defeat Smoking

 
 
Lewis Fein a marketing adviser for QUIT WTR joins eHealth Radio and the Health News and Smoking Cessation Channels.
 
Listen to interview with host Eric Michaels & guest Lewis Fein discuss the following:
For the benefit of our listeners, please tell us what QUIT WTR is?
How does QUIT WTR work?
What are some of the key advantages of QUIT WTR?
Tell us more about the natural ingredients of QUIT WTR.
What else should our listeners know about QUIT WTR?

Lewis Fein is a media relations consultant, specializing in design, branding, and product development. A graduate of The Emory University School of Law, Lewis is a frequent commentator on personal and professional messaging. A guest on various shows, including KABC Talk Radio and Fox News, Lewis resides in Southern California.
 
 
Website: quitwater.com
Facebook: facebook.com/quitwtr